Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation
|
Immix Biopharma, Inc.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/23/2023 |
4
| Chudnovsky Yekaterina (10% Owner) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Granted 20,000 options to buy
@ $1.8, valued at
$36k
Granted 16,670 options to buy
@ $1.8, valued at
$30k
|
|
08/23/2023 |
3
| Chudnovsky Yekaterina (10% Owner) has filed a Form 3 on Immix Biopharma, Inc. |
08/14/2023 |
4
| BUCHAN MELISSA JANE (Director) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Granted 20,000 options
@ $1.86, valued at
$37.2k
|
|
08/14/2023 |
4
| Morris Gabriel S (CFO) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Granted 193,000 options
@ $1.86, valued at
$359k
|
|
08/14/2023 |
4
| Rachman Ilya M (CEO and Chairman) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Granted 193,000 options
@ $1.86, valued at
$359k
|
|
08/14/2023 |
4
| Ng Carey (Director) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Granted 20,000 options
@ $1.86, valued at
$37.2k
|
|
08/14/2023 |
4
| Adams Helen C. (Director) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Granted 20,000 options
@ $1.86, valued at
$37.2k
|
|
08/14/2023 |
4
| Hsu Jason (Director) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Granted 20,000 options
@ $1.86, valued at
$37.2k
|
|
08/14/2023 |
4
| Marquet Magda (Director) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Granted 20,000 options
@ $1.86, valued at
$37.2k
|
|
11/15/2022 |
4
| Rachman Ilya M (CEO and Chairman) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Bought 4,050 shares
@ $1.019, valued at
$4.1k
Bought 1,000 shares
@ $0.95, valued at
$950 Bought 150 shares
@ $0.99, valued at
$148.5 |
|
11/15/2022 |
4
| Morris Gabriel S (CFO) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Bought 5,200 shares
@ $0.94, valued at
$4.9k
|
|
07/22/2022 |
4/A
| Senn Sean (Under 10% owner) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Sold 200 shares
@ $2.75, valued at
$550 |
|
07/18/2022 |
4
| Senn Sean (10% Owner) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Sold 200 shares
@ $2.75, valued at
$550 |
|
07/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/18/2022 |
4
| Rachman Ilya M (CEO and Chairman) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Granted 250,000 options
@ $2.64, valued at
$660k
|
|
07/18/2022 |
4
| Ng Carey (Director) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Granted 16,000 options
@ $2.64, valued at
$42.2k
|
|
07/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/18/2022 |
4
| Hsu Jason (Director) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Granted 16,000 options
@ $2.64, valued at
$42.2k
|
|
07/18/2022 |
4
| Morris Gabriel S (CFO) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Granted 250,000 options
@ $2.64, valued at
$660k
|
|
01/18/2022 |
3
| Senn Sean (10% Owner) has filed a Form 3 on Immix Biopharma, Inc. |
12/20/2021 |
4
| Rachman Ilya M (CEO and Chairman) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Bought 2,500 shares
@ $5, valued at
$12.5k
|
|
12/20/2021 |
4
| Hsu Jason (Director) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Converted 3,915,913 shares
@ $0.85, valued at
$3.3M
Bought 50,000 shares
@ $5, valued at
$250k
Converted convertible notes
@ $0.85, valued at
$0 |
|
12/20/2021 |
4
| Torchilin Vladimir P (Scientific Co-Founder) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Bought 2,200 shares
@ $4.47, valued at
$9.8k
Bought 3,000 shares
@ $5, valued at
$15k
|
|
12/20/2021 |
4
| Morris Gabriel S (CFO) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Converted 74,116 shares
@ $0.85, valued at
$63k
Converted 123,527 shares
@ $0.85, valued at
$105k
Converted 123,176 shares
@ $0.85, valued at
$104.7k
Bought 2,000 shares
@ $5, valued at
$10k
Converted convertible notes
@ $0.85, valued at
$0 Converted convertible notes
@ $0.85, valued at
$0 |
|
12/20/2021 |
4
| Ng Carey (Director) has filed a Form 4 on Immix Biopharma, Inc.
Txns:
| Converted 1,000,221 shares
@ $0.85, valued at
$850.2k
Bought 25,000 shares
@ $5, valued at
$125k
Converted convertible notes
@ $0.85, valued at
$0 |
|
12/15/2021 |
3
| BUCHAN MELISSA JANE (Director) has filed a Form 3 on Immix Biopharma, Inc. |
12/15/2021 |
3
| Torchilin Vladimir P (Scientific Co-Founder) has filed a Form 3 on Immix Biopharma, Inc. |
12/15/2021 |
3
| Rachman Ilya M (CEO and Chairman) has filed a Form 3 on Immix Biopharma, Inc. |
12/15/2021 |
3
| Hsu Jason (Director) has filed a Form 3 on Immix Biopharma, Inc. |
12/15/2021 |
3
| Morris Gabriel S (CFO) has filed a Form 3 on Immix Biopharma, Inc. |
12/15/2021 |
3
| Adams Helen C. (Director) has filed a Form 3 on Immix Biopharma, Inc. |
12/15/2021 |
3
| Marquet Magda (Director) has filed a Form 3 on Immix Biopharma, Inc. |
12/15/2021 |
3
| Ross Graham (CMO & Head of Clinical Dev.) has filed a Form 3 on Immix Biopharma, Inc. |
|
|